CD44 and neoplasm: Our findings that both IFDUC1 and TRIDUC1 ADSC lines had lower levels of the marker genes (CD105, CD73, CD90, CD44, CD106) when compared with NORMA1-4, supports a link with impaired tumor ADSC differentiation into osteogenic and chondrogenic lineages.